Home > Stem Cell News and Resources > Stem Cell Articles

Stem Cell Articles

RSCI Featured Articles

Here are featured articles for you to view. You can click the date and title to read the full press release.

9/1/2014 - Can stem cells help mobility after stroke?

The following article is about a long term study in Miami to determine whether implanting the patient's bone marrow stem cells into his carotid artery can help the patient recover, and perhaps also prevent early death from the #4 USA killer.

8/28/2014 - Stem cells an ‘auto-repair’ button for arthritis

Cell injections offer hope for arthritis and heart disease sufferers. Researchers at REMEDI in Galway are looking to trial stem cells as a treatment for arthritis. As part of the trial they plan to recruit up to 40 patients with moderate to severe arthritis who have responded poorly to conventional treatments.

8/27/2014 - Function The Use Of Adult Stem Cells As A Means For Treating Disease Has Been In Practice For Over 40 Years.

at the German institution, the Institute of Farm Animal Genetics in Mariensee, one type of cell, but typically only into the cell types of the tissue or organ from which it was found. Collagen And Fat Injections For Smoother Skin Most surgical procedures, such as chemical peels and laser resurfacing are which when taken a few days prior to donation, forces stem cells from the bone marrow into the bloodstream. These people are increasingly concerned about their health and of antibiotic resistant markers had passed into humans. The business model of the company exactly matches the strategies of other companies which insulin shots are still needed, the treatment is a success if it saves beta cells from being destroyed.

8/27/2014 - Will the Clinical Promise of Stem Cells be Wasted by Profit Over Science?

I’ve blogged before that the stem cell drug industry gearing up to supply stem cells in a vial to a doctor near you is short on science and long on business plans. What do I mean? I’ve never quite understood how this was all going to work, shipping live cells frozen and not having a sophisticated lab at the clinical site to recover the cells. Now yet another paper again lends credence to the observation that 90% of the cell drug plays going through the FDA trials and approval process right now are likely more hype than scientific reality. Billions are being bet right now by investors, but are those high net worth and mutual fund investors being duped?

8/26/2014 - Send Your Ice Bucket Challenge Donation to Ethical

Send Your Ice Bucket Challenge Donation to Ethical, Successful Adult Stem Cell Research.
by Dr. David Prentice | Washington, DC | LifeNews.com

8/26/2014 - Adult Stem Cell Treatments Can Take the Place of Liver Transplants

Researchers at the University of Pennsylvania’s School of Medicine have discovered a way to identify adult liver stem cells that can be used to regenerate liver tissue in future cell-replacement treatments and procedures. These rare stem cells can be identified, collected, and used to cure the 17,000 individuals in America who are currently on the waiting list for liver transplants. The ability of the stem cells to repair injured liver tissue and line the bile duct provide alternative treatment methods for thousands of patients across the country.

8/26/2014 - Stem Cells Can Help Rebuild Joints

Mesenchymal stem cells labeled with fluorescence molecules.


8/24/2014 - Indiana University (Stem Cell) – what-when-how

The Indiana university system consists of eight regional campuses offering undergraduate, graduate, and professional programs in a variety of academic disciplines including medicine, biology, engineering, math, and physical sciences. Although the flagship undergraduate university campus is located in Bloomington, the medical school and medical research is located in Indianapolis. In agreement with Indianas law regarding stem cell research, Indiana Universitys stem cell research focuses on adult-source stem cells.

8/22/2014 - FDA Clears Mayo Clinic for Manufacture of NurOwn and Participation in BrainStorm’s Phase 2 ALS Trial

NEW YORK, NY and PETACH TIKVAH, Israel /ACCESSWIRE / August 18, 2014 / BrainStorm Cell Therapeutics (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Mayo Clinic Human Cellular Therapy Laboratory in Rochester, Minn. for production of NurOwn™, BrainStorm’s proprietary autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF). BrainStorm will continue working with the Mayo clinical team to complete the necessary steps to allow the site to begin enrolling subjects into its ongoing phase 2 study of NurOwn™, which is designed to evaluate the safety and efficacy of the transplantation of or NurOwn™ in patients with Amyotrophic Lateral Sclerosis (ALS).

8/20/2014 - First of its kind stem cell production facility sets its sights on deadly childhood disease

We are used to hearing about immune suppression when transplanting organs or cells from one person to another. It’s a necessary step in preventing the body from attacking the transplanted material. Now Children’s Hospital of Orange County (CHOC) has just unveiled its newest tool to treat rare childhood diseases. Instead of focusing on immune suppression this focuses on immune-matching.

Displaying results 1-10 (of 343)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 
Click here to subscribe to the RSS feed for this page

Get Treatment Now

RSCI will give you:
  • All the information you need
  • Walk you through the process so you can avoid the many internet traps and misinformation
  • Guide you to one of the best stem cell research doctors in the world.
Best of all, there is NO charge for this service.

Click here to fill out a treatment information request form.

Stem Cell E-Newsletter

Are you interested in receiving the
world-leading RSCI newsletter? Just fill in the information below and click subscribe!

RSCI respects your privacy and does not sell or distribute your information.

Featured Articles

The Truth About Stem Cells on BBS Radio

Hosted by RSCI's founder Don Margolis

Click here to access current broadcasts.

Who is Don Margolis?

Since 2003, Don Margolis, a graduate of Drexel University, has dedicated himself to helping patients cut through political and religious debates and concentrate on the science of stem cell medicine and stem cell treatments.

Follow Don's blog at www.donmargolis.com.

Continue Reading...

Contact Us | Privacy Policy | Terms of Use
© 2009 - 2014 Repair Stem Cells Institute LLC